Linda Peckel

Articles

Treatment Delays Onset of Diabetes in At-Risk Populations

June 19, 2019

A single course of treatment with teplizumab delayed the development of type 1 diabetes in at-risk teens and children, shows a study presented at the American Diabetes Association annual meeting earlier this month.